Answers are grounded in this paper and cite their sources.
In patients with MSSA bacteremia where cephalosporins are used as firstline therapy, the CzIE was associated with increased 30-day mortality. Clinicians should be cautious when using cefazolin as firstline therapy for these infections.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: